📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Empagliflozin in Patients with Chronic Kidney Disease. (2023)

First Author: The EMPA-KIDNEY Collaborative Group

Attributed to: Adiposity and kidney disease: observations from large blood-based prospective cohorts across a wide range of different populations funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2204233

PubMed Identifier: 36331190

Publication URI: http://europepmc.org/abstract/MED/36331190

Type: Journal Article/Review

Volume: 388

Parent Publication: The New England journal of medicine

Issue: 2

ISSN: 0028-4793